Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27853180)
Watch
English
Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer
scientific article published on 14 July 2015
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
PubMed ID
26125448
retrieved
13 November 2016
title
Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer
(English)
1 reference
stated in
PubMed
PubMed ID
26125448
retrieved
13 November 2016
main subject
phase II clinical trial
0 references
lung cancer
1 reference
based on heuristic
inferred from title
docetaxel
1 reference
based on heuristic
inferred from title
author name string
P A Jänne
series ordinal
1
0 references
I Smith
series ordinal
2
0 references
G McWalter
series ordinal
3
0 references
H Mann
series ordinal
4
0 references
B Dougherty
series ordinal
5
0 references
J Walker
series ordinal
6
0 references
M C M Orr
series ordinal
7
0 references
D R Hodgson
series ordinal
8
0 references
A T Shaw
series ordinal
9
0 references
J R Pereira
series ordinal
10
0 references
G Jeannin
series ordinal
11
0 references
J Vansteenkiste
series ordinal
12
0 references
C H Barrios
series ordinal
13
0 references
F A Franke
series ordinal
14
0 references
L Crinò
series ordinal
15
0 references
P Smith
series ordinal
16
0 references
language of work or name
English
0 references
publication date
14 July 2015
0 references
published in
British Journal of Cancer
0 references
volume
113
0 references
issue
2
0 references
page(s)
199-203
0 references
copyright license
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International
start time
30 June 2015
1 reference
stated in
April 2022 Public Data File from Crossref
copyright status
copyrighted
0 references
cites work
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506393
retrieved
20 March 2017
Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506393
retrieved
20 March 2017
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506393
retrieved
20 March 2017
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506393
retrieved
20 March 2017
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506393
retrieved
20 March 2017
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506393
retrieved
20 March 2017
Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506393
retrieved
29 September 2017
Panel based MALDI-TOF tumour profiling is a sensitive method for detecting mutations in clinical non small cell lung cancer tumour
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506393
retrieved
29 September 2017
Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506393
retrieved
29 September 2017
KRAS mutations as prognostic and predictive markers in non-small cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506393
retrieved
29 September 2017
The BATTLE trial: personalizing therapy for lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506393
retrieved
29 September 2017
Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBJC.2015.215
retrieved
21 January 2018
Identifiers
DOI
10.1038/BJC.2015.215
0 references
Dimensions Publication ID
1049491576
0 references
PMCID
4506393
1 reference
stated in
PubMed
PubMed ID
26125448
retrieved
13 November 2016
PubMed ID
26125448
1 reference
stated in
PubMed
PubMed ID
26125448
retrieved
13 November 2016
ResearchGate publication ID
279456822
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
